|
G
|
Abhd4
|
abhydrolase domain containing 4, N-acyl phospholipase B
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of ABHD4 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G
|
Acly
|
ATP citrate lyase
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ACLY mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,412,049...85,463,320
|
|
G
|
Actb
|
actin, beta
|
increases mutagenesis
|
EXP
|
Methylnitrosourea results in increased mutagenesis of ACTB gene
|
CTD |
PMID:10767621 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
|
|
G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ADAMTS1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
|
|
G
|
Afp
|
alpha-fetoprotein
|
decreases response to substance
|
EXP
|
AFP protein modified form results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:16322315 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,573,412...17,591,480
|
|
G
|
Agtr1b
|
angiotensin II receptor, type 1b
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of AGTR1B mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:102,844,969...102,920,232
|
|
G
|
Akr1b10
|
aldo-keto reductase family 1 member B10
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of AKR1B10 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
|
|
G
|
Akr1b8
|
aldo-keto reductase family 1, member B8
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of AKR1B8 protein
|
CTD |
PMID:11565795 |
|
NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:62,997,161...63,010,097
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of AKT1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of AKT1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:15581186 PMID:22465879 PMID:25164625 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Akt2
|
AKT serine/threonine kinase 2
|
multiple interactions
|
EXP
|
[Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein
|
CTD |
PMID:22245120 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
|
|
G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of ALDH1A1 mRNA
|
CTD |
PMID:25922126 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
|
|
G
|
Angptl4
|
angiopoietin-like 4
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ANGPTL4 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G
|
Ap3s1
|
adaptor related protein complex 3 subunit sigma 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of AP3S1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr18:39,462,728...39,531,622
Ensembl chr18:39,462,765...39,531,622
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of APAF1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
increases response to substance
|
ISO
|
APC gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:12096346 |
|
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
|
|
G
|
Aqp1
|
aquaporin 1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of AQP1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
|
|
G
|
Areg
|
amphiregulin
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of AREG mRNA
|
CTD |
PMID:20732338 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
|
|
G
|
Asip
|
agouti signaling protein
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of A gene
|
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:143,555,696...143,561,171
|
|
G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of ASNS mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G
|
Atf1
|
activating transcription factor 1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of ATF1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G
|
Atp6v1f
|
ATPase H+ transporting V1 subunit F
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of ATP6V1F gene
|
CTD |
PMID:16868089 |
|
NCBI chr 4:59,033,020...59,035,980
|
|
G
|
Atr
|
ATR serine/threonine kinase
|
affects localization multiple interactions
|
ISO
|
Methylnitrosourea affects the localization of ATR protein MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]
|
CTD |
PMID:21285353 |
|
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:96,426,724...96,524,136
|
|
G
|
Aurka
|
aurora kinase A
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
[Estrogens co-treated with Progesterone] inhibits the reaction [Methylnitrosourea results in increased expression of AURKA mRNA] Methylnitrosourea results in decreased expression of AURKA mRNA
|
CTD |
PMID:12124350 PMID:27233451 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
|
|
G
|
Aurkb
|
aurora kinase B
|
decreases phosphorylation
|
ISO
|
Methylnitrosourea results in decreased phosphorylation of AURKB protein
|
CTD |
PMID:27233451 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
|
|
G
|
Axin1
|
axin 1
|
decreases expression
|
EXP
|
N-methyl-N-nitrosourea decreases expression of Axin1 mRNA in colon
|
RGD |
PMID:28032729 |
RGD:150530464 |
NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,163,684...15,215,615
|
|
G
|
B3galt1
|
Beta-1,3-galactosyltransferase 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of B3GALT1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:52,253,618...52,825,313
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAD mRNA
|
CTD |
PMID:20732338 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased expression of BAX protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of BAX mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] Methylnitrosourea results in increased expression of BAX mRNA; Methylnitrosourea results in increased expression of BAX protein
|
CTD |
PMID:16011256 PMID:16047940 PMID:16168987 PMID:20732338 PMID:22465879 PMID:28688903 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl10
|
BCL10, immune signaling adaptor
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of BCL10 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:234,840,858...234,850,523
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression increases expression
|
EXP ISO
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein; [Methylnitrosourea co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein] Methylnitrosourea results in increased expression of BCL2 mRNA
|
CTD |
PMID:15240709 PMID:16011256 PMID:16047940 PMID:20732338 PMID:22465879 PMID:24463056 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Bdnf
|
brain-derived neurotrophic factor
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of BDNF mRNA
|
CTD |
PMID:28688903 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of BIRC5 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
|
|
G
|
Bmp5
|
bone morphogenetic protein 5
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of BMP5 gene
|
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:76,517,164...76,639,925
|
|
G
|
Bpnt1
|
3'(2'), 5'-bisphosphate nucleotidase 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of BPNT1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr13:99,397,127...99,425,056
Ensembl chr13:96,868,580...96,893,503
|
|
G
|
Btg2
|
BTG anti-proliferation factor 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of BTG2 mRNA
|
CTD |
PMID:21382384 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
|
|
G
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of BUB1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:115,020,254...115,051,650
|
|
G
|
Capn1
|
calpain 1
|
decreases activity
|
EXP
|
Methylnitrosourea results in decreased activity of CAPN1 protein
|
CTD |
PMID:17069801 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G
|
Capn2
|
calpain 2
|
increases activity
|
EXP
|
Methylnitrosourea results in increased activity of CAPN2 protein
|
CTD |
PMID:17069801 |
|
NCBI chr13:96,681,902...96,732,625
Ensembl chr13:94,150,240...94,200,969
|
|
G
|
Car2
|
carbonic anhydrase 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CAR2 mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO EXP
|
MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]] [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP3 protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of CASP3 mRNA
|
CTD |
PMID:13679151 PMID:20732338 PMID:22465879 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp6
|
caspase 6
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CASP6 mRNA
|
CTD |
PMID:28688903 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions increases expression
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA Methylnitrosourea results in increased expression of CASP8 mRNA
|
CTD |
PMID:20732338 PMID:22465879 PMID:28688903 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA
|
CTD |
PMID:20732338 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
decreases activity multiple interactions
|
EXP
|
Methylnitrosourea results in decreased activity of CAT protein [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased activity of CAT protein
|
CTD |
PMID:39197506 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Cbr1
|
carbonyl reductase 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CBR1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression multiple interactions
|
EXP ISO
|
Methylnitrosourea results in increased expression of CCL2 mRNA Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]
|
CTD |
PMID:16822543 PMID:17412507 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G
|
Ccl20
|
C-C motif chemokine ligand 20
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CCL20 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
|
|
G
|
Ccl3
|
C-C motif chemokine ligand 3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CCL3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
|
|
G
|
Ccl4
|
C-C motif chemokine ligand 4
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CCL4 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CCL5 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
|
|
G
|
Ccn2
|
cellular communication network factor 2
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of CCN2 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
|
|
G
|
Ccn3
|
cellular communication network factor 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of CCN3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:86,094,000...86,101,019
|
|
G
|
Ccna2
|
cyclin A2
|
increases expression decreases expression
|
ISO
|
Methylnitrosourea results in increased expression of CCNA2 mRNA; Methylnitrosourea results in increased expression of CCNA2 protein Methylnitrosourea results in decreased expression of CCNA2
|
CTD |
PMID:15870882 PMID:18593901 PMID:25270620 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
|
|
G
|
Ccnb1
|
cyclin B1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CCNB1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G
|
Ccnd1
|
cyclin D1
|
increases expression multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of CCND1 protein [Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein]
|
CTD |
PMID:18155124 PMID:20732338 PMID:25164625 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
|
|
G
|
Ccnd3
|
cyclin D3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CCND3 protein
|
CTD |
PMID:18155124 |
|
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371
|
|
G
|
Cd59b
|
CD59b molecule
|
multiple interactions decreases lipidation
|
EXP
|
[Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein Methylnitrosourea results in decreased lipidation of CD59 protein
|
CTD |
PMID:19965957 PMID:20202993 PMID:27931811 |
|
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:90,459,162...90,478,847
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions decreases expression
|
EXP ISO
|
[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA; [Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein] Methylnitrosourea results in decreased expression of CDH1 mRNA
|
CTD |
PMID:25164625 PMID:27221058 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
|
|
G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein]
|
CTD |
PMID:25164625 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:7,776,704...7,990,167
|
|
G
|
Cdh22
|
cadherin 22
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of CDH22 mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:153,845,787...153,970,588
|
|
G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression increases expression
|
ISO EXP
|
Methylnitrosourea results in decreased expression of CDK1 Methylnitrosourea results in increased expression of CDK1 mRNA Methylnitrosourea results in increased expression of CDK1 protein
|
CTD |
PMID:15870882 PMID:16525678 PMID:18593901 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
|
|
G
|
Cdk2
|
cyclin dependent kinase 2
|
increases activity
|
EXP
|
Methylnitrosourea results in increased activity of CDK2 protein
|
CTD |
PMID:15581186 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
|
|
G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
increases cleavage
|
EXP
|
Methylnitrosourea results in increased cleavage of CDK5R1 protein
|
CTD |
PMID:17069801 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G
|
Cdk5rap1
|
CDK5 regulatory subunit associated protein 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of CDK5RAP1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 3:142,838,081...142,872,669
Ensembl chr 3:142,708,028...142,872,677
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression decreases expression
|
ISO EXP
|
Methylnitrosourea results in increased expression of CDKN1A mRNA Methylnitrosourea results in decreased expression of CDKN1A protein
|
CTD |
PMID:15581186 PMID:18593901 PMID:28688903 PMID:29110037 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G
|
Cel
|
carboxyl ester lipase
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CEL mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G
|
Cela2a
|
chymotrypsin like elastase 2A
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CELA2A mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
|
|
G
|
Cenpa
|
centromere protein A
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of CENPA mRNA
|
CTD |
PMID:27233451 |
|
NCBI chr 6:31,420,062...31,431,703
Ensembl chr 6:25,700,142...25,711,675
|
|
G
|
Cenpe
|
centromere protein E
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CENPE mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:223,636,998...223,695,669
|
|
G
|
Cep290
|
centrosomal protein 290
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of CEP290 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
|
|
G
|
Chek2
|
checkpoint kinase 2
|
increases phosphorylation multiple interactions
|
ISO
|
Methylnitrosourea results in increased phosphorylation of CHEK2 protein MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein]
|
CTD |
PMID:21285353 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
|
|
G
|
Ckap5
|
cytoskeleton associated protein 5
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CKAP5 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:97,946,966...98,049,050
Ensembl chr 3:77,491,276...77,593,264
|
|
G
|
Cldn7
|
claudin 7
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of CLDN7 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:54,689,987...54,692,171
|
|
G
|
Clu
|
clusterin
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CLU mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
|
|
G
|
Col4a3
|
collagen type IV alpha 3 chain
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of COL4A3 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
|
|
G
|
Col5a3
|
collagen type V alpha 3 chain
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of COL5A3 mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G
|
Cpt1c
|
carnitine palmitoyltransferase 1c
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CPT1C mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:95,442,817...95,457,342
|
|
G
|
Cradd
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of CRADD gene
|
CTD |
PMID:16868089 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions
|
EXP
|
[bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein
|
CTD |
PMID:34186418 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
|
|
G
|
Crem
|
cAMP responsive element modulator
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CREM mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989
|
|
G
|
Crip2
|
cysteine-rich protein 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CRIP2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G
|
Csf2
|
colony stimulating factor 2
|
multiple interactions increases expression
|
ISO
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]
|
CTD |
PMID:16822543 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
|
|
G
|
Ctcf
|
CCCTC-binding factor
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of CTCF mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G
|
Ctnnb1
|
catenin beta 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of CTNNB1 protein
|
CTD |
PMID:12096346 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G
|
Cwc27
|
CWC27 spliceosome associated cyclophilin
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of CWC27 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:35,764,674...35,975,908
Ensembl chr 2:35,764,686...35,975,872
|
|
G
|
Cxcr1
|
C-X-C motif chemokine receptor 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of CXCR1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of CYP27B1 mRNA
|
CTD |
PMID:21843606 |
|
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:62,871,297...62,876,241
|
|
G
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of CYP2J9 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
|
|
G
|
Dapk1
|
death associated protein kinase 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of DAPK1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,930,213...4,090,991
|
|
G
|
Dbi
|
diazepam binding inhibitor
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of DBI mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
|
|
G
|
Dbp
|
D-box binding PAR bZIP transcription factor
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of DBP mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:96,175,440...96,180,745
|
|
G
|
Dcaf4
|
DDB1 and CUL4 associated factor 4
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of DCAF4 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
|
|
G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of DDIT4L mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G
|
Depdc7
|
DEP domain containing 7
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of DEPDC7 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G
|
Dio1
|
iodothyronine deiodinase 1
|
multiple interactions
|
EXP
|
Methylnitrosourea inhibits the reaction [Iodine results in increased expression of DIO1 mRNA]
|
CTD |
PMID:15922087 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G
|
Dlgap1
|
DLG associated protein 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of DLGAP1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
|
|
G
|
Dmbt1
|
deleted in malignant brain tumors 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of DMBT1 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G
|
Dnajb5
|
DnaJ heat shock protein family (Hsp40) member B5
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of DNAJB5 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:57,176,845...57,185,490
|
|
G
|
Dnajc7
|
DnaJ heat shock protein family (Hsp40) member C7
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of DNAJC7 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
|
|
G
|
Dnpep
|
aspartyl aminopeptidase
|
decreases activity
|
EXP
|
Methylnitrosourea results in decreased activity of DNPEP protein
|
CTD |
PMID:16537183 |
|
NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716
|
|
G
|
Dpysl3
|
dihydropyrimidinase-like 3
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of DPYSL3 mRNA
|
CTD |
PMID:28688903 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G
|
Dusp5
|
dual specificity phosphatase 5
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of DUSP5 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:252,538,449...252,551,818
|
|
G
|
Dym
|
dymeclin
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of DYM gene
|
CTD |
PMID:16868089 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G
|
Ech1
|
enoyl-CoA hydratase 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of ECH1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G
|
Edf1
|
endothelial differentiation-related factor 1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of EDF1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G
|
Ednrb
|
endothelin receptor type B
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of EDNRB gene
|
CTD |
PMID:17174358 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
|
|
G
|
Eed
|
embryonic ectoderm development
|
affects response to substance
|
ISO
|
EED protein affects the susceptibility to Methylnitrosourea
|
CTD |
PMID:11803473 |
|
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
|
|
G
|
Efna3
|
ephrin A3
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of EFNA3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:174,729,764...174,738,736
|
|
G
|
Efs
|
embryonal Fyn-associated substrate
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of EFS mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
|
|
G
|
Egf
|
epidermal growth factor
|
multiple interactions increases expression
|
EXP
|
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of EGF mRNA Methylnitrosourea results in increased expression of EGF mRNA
|
CTD |
PMID:39197506 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of EGFR protein]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein]; Methylnitrosourea results in increased phosphorylation of and results in decreased expression of EGFR protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein]
|
CTD |
PMID:22245120 PMID:25164625 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
|
|
G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of EGLN3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:71,650,297...71,675,766
|
|
G
|
Eif2s2
|
eukaryotic translation initiation factor 2 subunit beta
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of EIF2S2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of EIF4EBP1 protein
|
CTD |
PMID:22465879 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
|
|
G
|
Elovl6
|
ELOVL fatty acid elongase 6
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ELOVL6 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:218,063,804...218,171,186
|
|
G
|
Eomes
|
eomesodermin
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of EOMES mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:118,181,777...118,188,316
|
|
G
|
Ephx1
|
epoxide hydrolase 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of EPHX1 mRNA
|
CTD |
PMID:21382384 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
|
|
G
|
Ercc4
|
ERCC excision repair 4, endonuclease catalytic subunit
|
decreases expression increases expression
|
ISO
|
Methylnitrosourea results in decreased expression of ERCC4 mRNA Methylnitrosourea results in increased expression of ERCC4 mRNA
|
CTD |
PMID:16616109 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369 Ensembl chr10:2,419,038...2,448,369
|
|
G
|
Ergic3
|
ERGIC and golgi 3
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of ERGIC3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions increases response to substance decreases phosphorylation increases expression
|
EXP
|
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of ESR1 mRNA; [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in decreased phosphorylation of ESR1 protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]] ESR1 protein results in increased susceptibility to Methylnitrosourea Methylnitrosourea results in increased expression of ESR1 mRNA
|
CTD |
PMID:15528971 PMID:16891317 PMID:22245120 PMID:34186418 PMID:39197506 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
|
|
G
|
Ezr
|
ezrin
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of EZR mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G
|
F3
|
coagulation factor III, tissue factor
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of F3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
|
|
G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of FABP3 mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718
|
|
G
|
Faim2
|
Fas apoptotic inhibitory molecule 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of FAIM2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G
|
Fam187b
|
family with sequence similarity 187, member B
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of FAM187B mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 1:86,205,234...86,219,542
Ensembl chr 1:86,205,218...86,219,917
|
|
G
|
Fasn
|
fatty acid synthase
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of FASN mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
|
|
G
|
Fbp2
|
fructose-bisphosphatase 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of FBP2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,236,336...2,253,698
|
|
G
|
Fbxo15
|
F-box protein 15
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of FBXO15 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G
|
Fbxo5
|
F-box protein 5
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of FBXO5 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:42,196,068...42,202,437
|
|
G
|
Fgf1
|
fibroblast growth factor 1
|
multiple interactions
|
EXP
|
FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein]; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]
|
CTD |
PMID:16011256 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
|
|
G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein
|
CTD |
PMID:15581186 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
|
|
G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of and affects the localization of FGFR2 protein
|
CTD |
PMID:15581186 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
|
|
G
|
Fgfr4
|
fibroblast growth factor receptor 4
|
multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of and affects the localization of FGFR4 protein
|
CTD |
PMID:15581186 |
|
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,461,547...9,476,242
|
|
G
|
Fhit
|
fragile histidine triad diadenosine triphosphatase
|
increases methylation decreases expression
|
EXP
|
Methylnitrosourea results in increased methylation of FHIT intron; Methylnitrosourea results in increased methylation of FHIT promoter Methylnitrosourea results in decreased expression of FHIT mRNA; Methylnitrosourea results in decreased expression of FHIT protein
|
CTD |
PMID:15937960 PMID:17412507 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of FOS mRNA; Methylnitrosourea results in increased expression of FOS protein [tetramethylpyrazine affects the expression of FOS mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of FOS protein]
|
CTD |
PMID:16168987 PMID:16268501 PMID:17412507 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G
|
Foxa1
|
forkhead box A1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of FOXA1 mRNA
|
CTD |
PMID:27221058 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G
|
Foxa2
|
forkhead box A2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of FOXA2 mRNA
|
CTD |
PMID:27221058 |
|
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:135,470,131...135,474,326
|
|
G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions decreases expression
|
EXP
|
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in decreased expression of FSHB protein]
|
CTD |
PMID:22245120 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
|
|
G
|
Galnt16
|
polypeptide N-acetylgalactosaminyltransferase 16
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of GALNT16 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G
|
Galnt6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of GALNT6 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
|
|
G
|
Gbp2
|
guanylate binding protein 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of GBP2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression decreases expression
|
EXP
|
Methylnitrosourea results in increased expression of GFAP protein Methylnitrosourea results in decreased expression of GFAP mRNA
|
CTD |
PMID:18155124 PMID:28688903 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
|
|
G
|
Gh1
|
growth hormone 1
|
decreases response to substance
|
EXP
|
GH1 gene mutant form results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:12082019 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078
|
|
G
|
Gjb1
|
gap junction protein, beta 1
|
decreases response to substance
|
ISO
|
GJB1 protein results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:17463168 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G
|
Glipr1l2
|
GLIPR1 like 2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of GLIPR1L2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 7:47,533,009...47,546,737
Ensembl chr 7:47,515,623...47,546,014
|
|
G
|
Gmcl1
|
germ cell-less 1, spermatogenesis associated
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of GMCL1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 4:119,140,598...119,179,891
Ensembl chr 4:119,140,598...119,179,881
|
|
G
|
Gpx2
|
glutathione peroxidase 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of GPX2 mRNA; Methylnitrosourea results in increased expression of GPX2 protein
|
CTD |
PMID:18056462 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
|
|
G
|
Grb14
|
growth factor receptor bound protein 14
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of GRB14 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:49,568,210...49,683,889
|
|
G
|
Grb2
|
growth factor receptor bound protein 2
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 protein
|
CTD |
PMID:22465879 |
|
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
|
|
G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
decreases expression increases expression
|
EXP
|
Methylnitrosourea results in decreased expression of GRIN2A mRNA Methylnitrosourea results in increased expression of GRIN2A mRNA
|
CTD |
PMID:28688903 |
|
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein]
|
CTD |
PMID:25164625 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of H2AX protein modified form
|
CTD |
PMID:27233451 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G
|
Hba-a2
|
hemoglobin alpha, adult chain 2
|
increases carbamoylation
|
ISO
|
Methylnitrosourea results in increased carbamoylation of HBA1 protein
|
CTD |
PMID:15655799 |
|
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G
|
Hba-a3
|
hemoglobin alpha, adult chain 3
|
increases carbamoylation
|
ISO
|
Methylnitrosourea results in increased carbamoylation of HBA2 protein
|
CTD |
PMID:15655799 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G
|
Hbb
|
hemoglobin subunit beta
|
increases carbamoylation
|
ISO
|
Methylnitrosourea results in increased carbamoylation of HBB protein
|
CTD |
PMID:15655799 |
|
NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:158,120,200...158,252,012
|
|
G
|
Hdac6
|
histone deacetylase 6
|
multiple interactions
|
EXP
|
[bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein
|
CTD |
PMID:34186418 |
|
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:14,551,044...14,572,441
|
|
G
|
Hesx1
|
HESX homeobox 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of HESX1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr16:2,191,852...2,193,957
Ensembl chr16:2,191,852...2,193,957
|
|
G
|
Hgf
|
hepatocyte growth factor
|
decreases expression multiple interactions
|
ISO
|
Methylnitrosourea results in decreased expression of HGF mRNA Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of HGF mRNA]
|
CTD |
PMID:18675455 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
|
|
G
|
Hist1h2bc
|
histone cluster 1, H2bc
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of H2BC4 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr17:47,388,085...47,392,349
Ensembl chr17:42,694,723...42,696,642
|
|
G
|
Hivep2
|
HIVEP zinc finger 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of HIVEP2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:8,359,289...8,555,993
|
|
G
|
Hmgb2
|
high mobility group box 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of HMGB2 mRNA; Methylnitrosourea results in increased expression of HMGB2 protein
|
CTD |
PMID:16525678 PMID:29877212 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G
|
Hmgb3
|
high mobility group box 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of HMGB3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr X:154,341,106...154,346,087
Ensembl chr X:149,296,375...149,301,292
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of HMOX1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Hprt1
|
hypoxanthine phosphoribosyltransferase 1
|
increases mutagenesis increases expression
|
EXP ISO
|
Methylnitrosourea results in increased mutagenesis of HPRT1 gene Methylnitrosourea results in increased expression of HPRT1 mRNA
|
CTD |
PMID:18249417 PMID:25270620 |
|
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:132,736,096...132,768,154
|
|
G
|
Hras
|
HRas proto-oncogene, GTPase
|
multiple interactions decreases response to substance increases mutagenesis increases response to substance
|
ISO EXP
|
limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] HRAS protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased mutagenesis of HRAS gene
|
CTD |
PMID:10767621 PMID:11182032 PMID:11376698 PMID:11802805 PMID:11973638 PMID:12117780 PMID:15688392 PMID:28421967 More...
|
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
|
|
G
|
Id3
|
inhibitor of DNA binding 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of ID3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G
|
Ier3
|
immediate early response 3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of IER3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,928,378...2,929,583
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions decreases response to substance
|
ISO EXP
|
IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein IFNG protein results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:14736494 PMID:15240709 PMID:16080182 PMID:16822543 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G
|
Ifrd1
|
interferon-related developmental regulator 1
|
multiple interactions increases expression
|
ISO
|
Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IFRD1 mRNA]
|
CTD |
PMID:18675455 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G
|
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of IGDCC4 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 8:65,621,893...65,657,651
Ensembl chr 8:65,621,897...65,657,648
|
|
G
|
Igf1
|
insulin-like growth factor 1
|
increases response to substance
|
ISO
|
IGF1 protein results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:15528971 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
|
|
G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
multiple interactions increases expression
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R protein; Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased expression of IGF1R protein]
|
CTD |
PMID:16237195 PMID:22465879 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
|
|
G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of IGFBP2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G
|
Ikzf1
|
IKAROS family zinc finger 1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of IKZF1 mRNA
|
CTD |
PMID:16616109 |
|
NCBI chr14:90,468,696...90,556,522
Ensembl chr14:86,255,065...86,342,416
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein] Methylnitrosourea results in increased expression of IL10 mRNA; Methylnitrosourea results in increased expression of IL10 protein
|
CTD |
PMID:14999141 PMID:16822543 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G
|
Il17b
|
interleukin 17B
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of IL17B mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr18:55,141,194...55,145,565
Ensembl chr18:55,141,194...55,145,565
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
ISO EXP
|
Methylnitrosourea results in increased expression of IL1B mRNA Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IL1B mRNA]
|
CTD |
PMID:17412507 PMID:18675455 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il2
|
interleukin 2
|
multiple interactions increases expression
|
ISO EXP
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein] [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IL2 protein
|
CTD |
PMID:14736494 PMID:16822543 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G
|
Il4
|
interleukin 4
|
multiple interactions increases expression
|
ISO
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]
|
CTD |
PMID:16822543 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
|
|
G
|
Insr
|
insulin receptor
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of INSR protein
|
CTD |
PMID:16237195 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
|
|
G
|
Irf1
|
interferon regulatory factor 1
|
decreases response to substance increases expression
|
ISO EXP
|
IRF1 protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased expression of IRF1 mRNA
|
CTD |
PMID:15240709 PMID:17412507 |
|
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
multiple interactions increases phosphorylation
|
EXP
|
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased phosphorylation of IRS1 protein]
|
CTD |
PMID:16237195 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
|
|
G
|
Jam2
|
junctional adhesion molecule 2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of JAM2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression increases phosphorylation multiple interactions
|
EXP
|
Methylnitrosourea results in increased expression of JUN protein Methylnitrosourea results in increased phosphorylation of JUN protein [tetramethylpyrazine affects the expression of JUN mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of JUN protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of JUN protein]
|
CTD |
PMID:16168987 PMID:16268501 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of JUNB mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
|
|
G
|
Kif3b
|
kinesin family member 3B
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of KIF3B gene
|
CTD |
PMID:16868089 |
|
NCBI chr 3:162,218,621...162,258,191
Ensembl chr 3:141,758,466...141,797,963
|
|
G
|
Kitlg
|
KIT ligand
|
decreases expression multiple interactions
|
ISO
|
Methylnitrosourea results in decreased expression of KITL mRNA Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of KITL mRNA]
|
CTD |
PMID:18675455 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G
|
Klhl22
|
kelch-like family member 22
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of KLHL22 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr11:96,695,168...96,736,079
Ensembl chr11:83,190,891...83,231,770
|
|
G
|
Klk1
|
kallikrein 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of KLK1 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
decreases response to substance increases mutagenesis
|
EXP ISO
|
KRAS protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased mutagenesis of KRAS gene
|
CTD |
PMID:11973638 PMID:12483526 PMID:18062963 |
|
NCBI chr 4:179,916,255...179,949,613
|
|
G
|
Lcn2
|
lipocalin 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of LCN2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G
|
Lep
|
leptin
|
multiple interactions increases expression
|
ISO
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]
|
CTD |
PMID:16822543 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G
|
Lgals3
|
galectin 3
|
decreases expression increases expression
|
ISO EXP
|
Methylnitrosourea results in decreased expression of LGALS3 mRNA N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum
|
CTD RGD |
PMID:25270620 PMID:28032729 |
RGD:150530464 |
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
|
|
G
|
Ltb
|
lymphotoxin beta
|
decreases response to substance
|
ISO
|
LTB protein results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:15240709 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G
|
Macrod2
|
mono-ADP ribosylhydrolase 2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of MACROD2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G
|
Mad2l2
|
mitotic arrest deficient 2 like 2
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of MAD2L2 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:158,563,567...158,576,693
|
|
G
|
Madcam1
|
mucosal vascular addressin cell adhesion molecule 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of MADCAM1 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
multiple interactions
|
EXP
|
Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein
|
CTD |
PMID:12693035 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases response to substance multiple interactions
|
EXP
|
MAPK1 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK1 protein results in increased susceptibility to Methylnitrosourea 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK1 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK14 protein
|
CTD |
PMID:12693035 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases response to substance multiple interactions
|
EXP
|
MAPK3 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK3 protein results in increased susceptibility to Methylnitrosourea 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK3 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK3 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK3 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions decreases response to substance increases activity increases phosphorylation
|
ISO EXP
|
Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] MAPK8 gene mutant form results in decreased susceptibility to Methylnitrosourea Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK8 protein; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:12693035 PMID:16168987 PMID:18593901 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G
|
Mapkapk3
|
MAPK activated protein kinase 3
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of MAPKAPK3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:107,929,762...107,963,568
|
|
G
|
Mbp
|
myelin basic protein
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of MBP mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G
|
Mcam
|
melanoma cell adhesion molecule
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of MCAM mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G
|
Mdm2
|
MDM2 proto-oncogene
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MDM2 mRNA
|
CTD |
PMID:28688903 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G
|
Me1
|
malic enzyme 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ME1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G
|
Mgmt
|
O-6-methylguanine-DNA methyltransferase
|
increases alkylation multiple interactions decreases response to substance increases expression
|
ISO EXP
|
Methylnitrosourea results in increased alkylation of MGMT protein MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] Methylnitrosourea results in increased expression of MGMT mRNA
|
CTD |
PMID:8823159 PMID:11276365 PMID:11536039 PMID:12663516 PMID:13679151 PMID:15870882 PMID:17507295 PMID:23288051 PMID:28688903 More...
|
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G
|
Mipol1
|
mirror-image polydactyly 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of MIPOL1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 6:74,755,293...75,090,403
Ensembl chr 6:74,755,395...75,086,811
|
|
G
|
Mir185
|
microRNA 185
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MIR185 mRNA
|
CTD |
PMID:30336191 |
|
NCBI chr11:82,664,716...82,664,795
Ensembl chr11:82,664,716...82,664,795
|
|
G
|
Mir96
|
microRNA 96
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MIR96 mRNA
|
CTD |
PMID:30336191 |
|
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of MKI67 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G
|
Mlf1
|
myeloid leukemia factor 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MLF1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 2:151,648,492...151,681,654
Ensembl chr 2:151,648,511...151,681,652
|
|
G
|
Mlh1
|
mutL homolog 1
|
multiple interactions affects response to substance
|
ISO
|
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] MLH1 protein affects the susceptibility to Methylnitrosourea
|
CTD |
PMID:12967659 PMID:13679151 PMID:16204460 |
|
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
|
|
G
|
Mlx
|
MAX dimerization protein MLX
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of MLX mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:86,019,216...86,024,326
Ensembl chr10:86,019,588...86,032,350
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MMP3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
|
|
G
|
Mpc1
|
mitochondrial pyruvate carrier 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of MPC1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:52,437,745...52,449,399
Ensembl chr 1:52,437,741...52,449,400
|
|
G
|
Mpg
|
N-methylpurine-DNA glycosylase
|
decreases response to substance increases response to substance
|
ISO
|
MPG protein results in decreased susceptibility to Methylnitrosourea MPG protein results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:15299078 PMID:16288039 PMID:17674369 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G
|
Mrpl47
|
mitochondrial ribosomal protein L47
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of MRPL47 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:115,507,842...115,520,093
Ensembl chr 2:115,500,264...115,518,994
|
|
G
|
Mrps31
|
mitochondrial ribosomal protein S31
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of MRPS31 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
|
|
G
|
Msc
|
musculin
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of MSC mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
|
|
G
|
Msh2
|
mutS homolog 2
|
multiple interactions affects response to substance increases response to substance
|
ISO
|
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]; Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] MSH2 protein affects the susceptibility to Methylnitrosourea MSH2 protein results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:12185594 PMID:16204460 PMID:21285353 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
|
|
G
|
Msh6
|
mutS homolog 6
|
multiple interactions
|
ISO
|
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein]
|
CTD |
PMID:16204460 |
|
NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:6,562,632...6,579,956
|
|
G
|
Mt1
|
metallothionein 1
|
multiple interactions increases expression
|
ISO
|
[Methylnitrosourea co-treated with Carrageenan] results in increased expression of MT1 protein Methylnitrosourea results in increased expression of MT1 protein
|
CTD |
PMID:15928667 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of MTHFD2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MTOR protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein]
|
CTD |
PMID:22465879 PMID:25164625 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Methylnitrosourea results in increased expression of MYC mRNA Methylnitrosourea results in decreased expression of MYC mRNA [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein
|
CTD |
PMID:16616109 PMID:17412507 PMID:25270620 PMID:34186418 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
|
|
G
|
Myo5a
|
myosin VA
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of MYO5A gene
|
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
|
|
G
|
Ncor2
|
nuclear receptor co-repressor 2
|
affects expression
|
EXP
|
Methylnitrosourea affects the expression of NCOR2 mRNA
|
CTD |
PMID:21843606 |
|
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
|
|
G
|
Nectin1
|
nectin cell adhesion molecule 1
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of NECTIN1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:44,101,776...44,189,787
|
|
G
|
Nes
|
nestin
|
increases expression increases methylation
|
EXP ISO
|
Methylnitrosourea results in increased expression of NES protein Methylnitrosourea results in increased methylation of NES gene
|
CTD |
PMID:18155124 PMID:25922126 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions increases expression
|
EXP
|
[Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine inhibits the reaction [Methylnitrosourea results in increased expression of NFKBIA protein]
|
CTD |
PMID:15960898 PMID:16098260 PMID:16762860 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G
|
Nme5
|
NME/NM23 family member 5
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of NME5 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr18:26,163,558...26,180,742
Ensembl chr18:26,163,555...26,180,794
|
|
G
|
Nnat
|
neuronatin
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of NNAT mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:146,226,407...146,228,834
|
|
G
|
Nnmt
|
nicotinamide N-methyltransferase
|
increases activity
|
EXP
|
Methylnitrosourea results in increased activity of NNMT protein
|
CTD |
PMID:6652621 |
|
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of NOS2 protein
|
CTD |
PMID:16052507 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G
|
Nrxn3
|
neurexin 3
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of NRXN3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:107,641,780...109,272,044
|
|
G
|
Ntm
|
neurotrimin
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of NTM mRNA
|
CTD |
PMID:25922126 |
|
NCBI chr 8:35,634,929...36,625,081
Ensembl chr 8:27,377,773...28,366,595
|
|
G
|
Nusap1
|
nucleolar and spindle associated protein 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of NUSAP1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:106,603,289...106,633,624
|
|
G
|
Oaf
|
out at first homolog
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of OAF mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
|
|
G
|
Oca2
|
OCA2 melanosomal transmembrane protein
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of OCA2 gene
|
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 1:116,252,026...116,581,838
Ensembl chr 1:107,116,278...107,446,074
|
|
G
|
Ogfrl1
|
opioid growth factor receptor-like 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of OGFRL1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
|
|
G
|
Opn4
|
opsin 4
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of OPN4 mRNA; Methylnitrosourea results in decreased expression of OPN4 protein
|
CTD |
PMID:16580133 |
|
NCBI chr16:9,920,408...9,929,580
Ensembl chr16:9,920,491...10,005,711
|
|
G
|
Pafah2
|
platelet-activating factor acetylhydrolase 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PAFAH2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
|
|
G
|
Parg
|
poly (ADP-ribose) glycohydrolase
|
increases response to substance
|
ISO
|
PARG gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:15282315 |
|
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,436,476...7,544,273
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases response to substance multiple interactions affects response to substance increases activity
|
ISO EXP
|
PARP1 gene mutant form results in increased susceptibility to Methylnitrosourea PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein]; PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] PARP1 protein affects the susceptibility to Methylnitrosourea Methylnitrosourea results in increased activity of PARP1 protein Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein]
|
CTD |
PMID:11850828 PMID:15282315 PMID:16052507 PMID:16168987 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Parp2
|
poly (ADP-ribose) polymerase 2
|
increases response to substance
|
ISO
|
PARP2 gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:12727891 |
|
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
|
|
G
|
Patj
|
PATJ, crumbs cell polarity complex component
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PATJ mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:113,062,118...113,364,807
|
|
G
|
Pbk
|
PDZ binding kinase
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PBK mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
|
|
G
|
Pc
|
pyruvate carboxylase
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of PC mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:201,804,267...201,898,380
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions increases expression
|
ISO EXP
|
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] Methylnitrosourea results in increased expression of PCNA protein [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PCNA protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein]
|
CTD |
PMID:16204460 PMID:18155124 PMID:25164625 PMID:39197506 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
|
|
G
|
Pdk1
|
pyruvate dehydrogenase kinase 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of PDK1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:56,705,871...56,733,038
|
|
G
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein]
|
CTD |
PMID:25164625 |
|
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,105,498...13,174,623
|
|
G
|
Perp
|
p53 apoptosis effector related to PMP22
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PERP mRNA
|
CTD |
PMID:21382384 PMID:25270620 |
|
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:13,542,067...13,554,511
|
|
G
|
Pfkp
|
phosphofructokinase, platelet
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of PFKP mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
EXP
|
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PGR protein
|
CTD |
PMID:39197506 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
|
|
G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PHLDA3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
|
|
G
|
Pias2
|
protein inhibitor of activated STAT, 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PIAS2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr18:72,883,008...72,989,486
Ensembl chr18:70,607,665...70,710,033
|
|
G
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of PIEZO1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr19:50,544,580...50,606,812
Ensembl chr19:50,544,582...50,606,501
|
|
G
|
Piga
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
multiple interactions increases mutagenesis
|
EXP
|
[Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein; Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein Methylnitrosourea results in increased mutagenesis of PIGA; Methylnitrosourea results in increased mutagenesis of PIGA gene
|
CTD |
PMID:19965957 PMID:20202993 PMID:22923490 PMID:27931811 |
|
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
|
|
G
|
Pinx1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of PINX1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr15:38,097,896...38,157,143
Ensembl chr15:38,097,886...38,157,140
|
|
G
|
Pkib
|
cAMP-dependent protein kinase inhibitor beta
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of PKIB mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
|
|
G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:18593901 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
|
|
G
|
Pms2
|
PMS1 homolog 2, mismatch repair system component
|
multiple interactions affects response to substance increases response to substance
|
ISO
|
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] PMS2 protein affects the susceptibility to Methylnitrosourea PMS2 protein results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:12967659 PMID:16204460 PMID:16426742 |
|
NCBI chr12:15,790,478...15,814,790
Ensembl chr12:10,676,764...10,701,066
|
|
G
|
Polb
|
DNA polymerase beta
|
increases response to substance
|
ISO
|
POLB gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:17166880 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases response to substance
|
ISO
|
PPARG gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:15930296 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G
|
Ppp1r10
|
protein phosphatase 1, regulatory subunit 10
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of PPP1R10 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,822,995...2,837,611
|
|
G
|
Praf2
|
PRA1 domain family, member 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PRAF2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr X:17,445,313...17,447,950
Ensembl chr X:14,773,420...14,775,909
|
|
G
|
Prc1
|
protein regulator of cytokinesis 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PRC1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G
|
Prdm14
|
PR/SET domain 14
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of PRDM14 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:10,864,137...10,876,666
Ensembl chr 5:6,082,442...6,092,712
|
|
G
|
Prl
|
prolactin
|
multiple interactions
|
EXP
|
[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Methylnitrosourea] results in increased expression of PRL protein
|
CTD |
PMID:39197506 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
|
|
G
|
Prune1
|
prune exopolyphosphatase 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of PRUNE1 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of PTEN mRNA
|
CTD |
PMID:16616109 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of PTGS2
|
CTD |
PMID:28688903 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Ptpn14
|
protein tyrosine phosphatase, non-receptor type 14
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of PTPN14 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr13:101,268,258...101,420,508
Ensembl chr13:101,268,416...101,414,088
|
|
G
|
Rara
|
retinoic acid receptor, alpha
|
increases mutagenesis multiple interactions increases expression
|
ISO EXP
|
Methylnitrosourea results in increased mutagenesis of RARA gene Cholecalciferol inhibits the reaction [Methylnitrosourea results in increased expression of RARA mRNA]
|
CTD |
PMID:16868089 PMID:21843606 |
|
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142
|
|
G
|
Rb1
|
RB transcriptional corepressor 1
|
increases phosphorylation
|
EXP
|
Methylnitrosourea results in increased phosphorylation of RB1 protein
|
CTD |
PMID:15581186 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
|
|
G
|
Rbck1
|
RANBP2-type and C3HC4-type zinc finger containing 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of RBCK1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005
|
|
G
|
Rbm4
|
RNA binding motif protein 4
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of RBM4 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 1:202,078,442...202,087,506
Ensembl chr 1:202,085,279...202,105,380
|
|
G
|
Rbm43
|
RNA binding motif protein 43
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of RBM43 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:36,394,431...36,404,757
Ensembl chr 3:36,395,346...36,404,816
|
|
G
|
Rbp4
|
retinol binding protein 4
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of RBP4 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
|
|
G
|
Reg1a
|
regenerating family member 1 alpha
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of REG1 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:110,892,453...110,895,570
|
|
G
|
Reg3b
|
regenerating family member 3 beta
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of REG3B mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:110,861,775...110,865,015
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions affects activity affects localization decreases expression increases expression
|
EXP
|
3-aminobenzamide inhibits the reaction [Methylnitrosourea results in decreased expression of RELA protein modified form]; [Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine promotes the reaction [Methylnitrosourea affects the localization of RELA protein] Methylnitrosourea affects the activity of RELA protein Methylnitrosourea results in decreased expression of RELA protein; Methylnitrosourea results in decreased expression of RELA protein modified form Methylnitrosourea results in increased expression of RELA protein
|
CTD |
PMID:15960898 PMID:16098260 PMID:16762860 PMID:17137578 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G
|
Rfx4
|
regulatory factor X4
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of RFX4 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 7:18,853,065...19,015,378
Ensembl chr 7:18,853,322...19,014,967
|
|
G
|
Rhbdf2
|
rhomboid 5 homolog 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of RHBDF2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
|
|
G
|
Rnase1
|
ribonuclease A family member 1, pancreatic
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of RNASE1 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
|
|
G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of RPS6KB1 protein
|
CTD |
PMID:22465879 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
|
|
G
|
RT1-A2
|
RT1 class Ia, locus A2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of RT1-A2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr20:4,872,720...4,876,425
|
|
G
|
Rxrg
|
retinoid X receptor gamma
|
affects expression
|
EXP
|
Methylnitrosourea affects the expression of RXRG mRNA
|
CTD |
PMID:21843606 |
|
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
|
|
G
|
S100a3
|
S100 calcium binding protein A3
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of S100A3 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
|
|
G
|
Scarb2
|
scavenger receptor class B, member 2
|
multiple interactions
|
EXP
|
[Dichlorvos co-treated with Methylnitrosourea] results in increased expression of SCARB2 protein
|
CTD |
PMID:37469457 |
|
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
|
|
G
|
Scg2
|
secretogranin II
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of SCG2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G
|
Scn10a
|
sodium voltage-gated channel alpha subunit 10
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of SCN10A mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G
|
Serpine2
|
serpin family E member 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of SERPINE2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
|
|
G
|
Sgk1
|
serum/glucocorticoid regulated kinase 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of SGK1 mRNA
|
CTD |
PMID:29110037 |
|
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:22,980,261...23,098,283
|
|
G
|
Shc1
|
SHC adaptor protein 1
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 protein
|
CTD |
PMID:22465879 |
|
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:174,837,930...174,849,536
|
|
G
|
Slc16a12
|
solute carrier family 16, member 12
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of SLC16A12 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
|
|
G
|
Slc25a53
|
solute carrier family 25, member 53
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of SLC25A53 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr X:100,306,917...100,319,662
Ensembl chr X:100,306,915...100,319,863
|
|
G
|
Slc26a4
|
solute carrier family 26 member 4
|
multiple interactions
|
EXP
|
Methylnitrosourea promotes the reaction [Iodine results in increased expression of SLC26A4 mRNA]
|
CTD |
PMID:15922087 |
|
NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:48,107,588...48,145,703
|
|
G
|
Slc4a1ap
|
solute carrier family 4 member 1 adaptor protein
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SLC4A1AP mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 6:24,905,941...24,933,651
Ensembl chr 6:24,905,941...24,933,815
|
|
G
|
Smad4
|
SMAD family member 4
|
increases response to substance
|
ISO
|
SMAD4 gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:12096346 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
|
|
G
|
Smad7
|
SMAD family member 7
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SMAD7 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:68,988,429...69,016,765
|
|
G
|
Smg6
|
SMG6 nonsense mediated mRNA decay factor
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SMG6 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:60,284,628...60,512,738
Ensembl chr10:59,786,258...60,014,395
|
|
G
|
Snai1
|
snail family transcriptional repressor 1
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA]
|
CTD |
PMID:25164625 |
|
NCBI chr 3:176,667,476...176,671,965
Ensembl chr 3:156,248,485...156,252,969
|
|
G
|
Snai2
|
snail family transcriptional repressor 2
|
multiple interactions decreases expression
|
EXP ISO
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA] Methylnitrosourea results in decreased expression of SNAI2 mRNA
|
CTD |
PMID:25164625 PMID:27221058 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:86,181,909...86,186,200
|
|
G
|
Snrnp35
|
small nuclear ribonucleoprotein U11/U12 subunit 35
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SNRNP35 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr12:32,112,032...32,119,829
Ensembl chr12:32,110,993...32,122,660
|
|
G
|
Snrpc
|
small nuclear ribonucleoprotein polypeptide C
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SNRPC mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr20:5,890,229...5,908,410
Ensembl chr20:5,888,453...5,906,638 Ensembl chr10:5,888,453...5,906,638
|
|
G
|
Socs3
|
suppressor of cytokine signaling 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of SOCS3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
|
|
G
|
Sod2
|
superoxide dismutase 2
|
affects metabolic processing multiple interactions
|
ISO
|
Methylnitrosourea affects the metabolism of SOD2 protein PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein]
|
CTD |
PMID:16052507 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
multiple interactions
|
EXP
|
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SOS1 mRNA
|
CTD |
PMID:22465879 |
|
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:14,533,360...14,611,107
|
|
G
|
Sphk1
|
sphingosine kinase 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of SPHK1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:101,758,711...101,764,240
|
|
G
|
Spink4
|
serine peptidase inhibitor, Kazal type 4
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of SPINK4 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 5:60,811,899...60,860,823
Ensembl chr 5:55,981,624...56,064,795
|
|
G
|
Spp1
|
secreted phosphoprotein 1
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of SPP1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
|
|
G
|
Spry2
|
sprouty RTK signaling antagonist 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of SPRY2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr15:89,106,809...89,111,926
Ensembl chr15:82,692,143...82,698,009
|
|
G
|
Sptan1
|
spectrin, alpha, non-erythrocytic 1
|
increases cleavage
|
EXP
|
Methylnitrosourea results in increased cleavage of SPTAN1 protein
|
CTD |
PMID:17069801 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions increases expression
|
EXP
|
Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of SRC protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of SRC protein]; Methylnitrosourea results in increased phosphorylation of and results in increased expression of SRC protein Methylnitrosourea results in increased expression of SRC protein
|
CTD |
PMID:22245120 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
|
|
G
|
Stat4
|
signal transducer and activator of transcription 4
|
increases response to substance
|
ISO
|
STAT4 gene mutant form results in increased susceptibility to Methylnitrosourea
|
CTD |
PMID:11418001 |
|
NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:49,419,340...49,588,540
|
|
G
|
Stmn1
|
stathmin 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of STMN1 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:146,681,436...146,687,154
|
|
G
|
Stmn2
|
stathmin 2
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of STMN2 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:93,204,692...93,252,011
|
|
G
|
Syp
|
synaptophysin
|
affects expression
|
EXP
|
Methylnitrosourea affects the expression of SYP protein
|
CTD |
PMID:18155124 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
|
|
G
|
Tcrg
|
T cell receptor gamma chain
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of TCRG gene
|
CTD |
PMID:16868089 |
|
NCBI chr17:45,622,041...45,666,123
|
|
G
|
Terc
|
telomerase RNA component
|
affects response to substance
|
ISO
|
TERC protein affects the susceptibility to Methylnitrosourea
|
CTD |
PMID:14612493 |
|
NCBI chr 2:112,815,654...112,816,041
|
|
G
|
Tff2
|
trefoil factor 2
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of TFF2 mRNA
|
CTD |
PMID:15240709 |
|
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
|
|
G
|
Tgif1
|
TGFB-induced factor homeobox 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TGIF1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
|
|
G
|
Thpo
|
thrombopoietin
|
multiple interactions increases expression
|
ISO
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]
|
CTD |
PMID:16822543 |
|
Ensembl chr11:80,182,820...80,188,167
|
|
G
|
Thra
|
thyroid hormone receptor alpha
|
affects expression
|
EXP
|
Methylnitrosourea affects the expression of THRA mRNA
|
CTD |
PMID:21843606 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:83,700,755...83,729,936
|
|
G
|
Thrb
|
thyroid hormone receptor beta
|
affects expression
|
EXP
|
Methylnitrosourea affects the expression of THRB mRNA
|
CTD |
PMID:21843606 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G
|
Thrsp
|
thyroid hormone responsive
|
decreases expression increases expression
|
EXP
|
Methylnitrosourea results in decreased expression of THRSP mRNA Methylnitrosourea results in increased expression of THRSP mRNA
|
CTD |
PMID:16525678 PMID:17341692 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G
|
Thumpd3
|
THUMP domain containing 3
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of THUMPD3 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 4:147,741,288...147,764,254
Ensembl chr 4:146,185,503...146,211,246
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TIMP1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
|
|
G
|
Tinagl1
|
tubulointerstitial nephritis antigen-like 1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TINAGL1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
|
|
G
|
Tkt
|
transketolase
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TKT mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G
|
Tmem69
|
transmembrane protein 69
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of TMEM69 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 5:130,004,888...130,008,466
Ensembl chr 5:130,004,901...130,010,655
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
ISO EXP
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein] Methylnitrosourea results in increased expression of TNF mRNA
|
CTD |
PMID:16822543 PMID:28688903 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
decreases expression
|
EXP
|
Methylnitrosourea results in decreased expression of TNFRSF11B mRNA
|
CTD |
PMID:17341692 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
|
|
G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TNFRSF12A mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:12,689,890...12,709,045
|
|
G
|
Tnip2
|
TNFAIP3 interacting protein 2
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TNIP2 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr14:76,228,350...76,245,553
Ensembl chr14:76,228,371...76,275,265
|
|
G
|
Top2a
|
DNA topoisomerase II alpha
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of TOP2A mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
|
|
G
|
Top3b
|
DNA topoisomerase III beta
|
decreases expression increases expression
|
ISO
|
Methylnitrosourea results in decreased expression of TOP3B mRNA Methylnitrosourea results in increased expression of TOP3B mRNA
|
CTD |
PMID:16616109 PMID:25270620 |
|
NCBI chr11:84,097,018...84,125,474
Ensembl chr11:84,097,026...84,125,392
|
|
G
|
Tor1b
|
torsin family 1, member B
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of TOR1B mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:14,243,181...14,249,279
Ensembl chr 3:14,243,243...14,249,272
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression increases phosphorylation increases response to substance affects response to substance increases stability
|
EXP ISO
|
[Estradiol co-treated with Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TP53 protein] Methylnitrosourea results in increased expression of TP53 mRNA Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein] TRP53 protein affects the susceptibility to Methylnitrosourea Methylnitrosourea results in increased expression of and results in increased phosphorylation of TP53 protein; TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein] Methylnitrosourea results in increased stability of TP53 protein
|
CTD |
PMID:11536039 PMID:11850828 PMID:12185594 PMID:17412507 PMID:18593901 PMID:20732338 PMID:21285353 PMID:27233451 PMID:28688903 PMID:29110037 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of TP53BP1 protein
|
CTD |
PMID:27233451 |
|
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
|
|
G
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of TRP53INP1 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G
|
Trip6
|
thyroid hormone receptor interactor 6
|
decreases expression
|
ISO
|
Methylnitrosourea results in decreased expression of TRIP6 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr12:19,386,212...19,390,619
Ensembl chr12:19,386,014...19,390,618
|
|
G
|
Tspo
|
translocator protein
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of TSPO mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G
|
Ttk
|
Ttk protein kinase
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of TTK mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:84,754,315...84,792,651
|
|
G
|
Twist1
|
twist family bHLH transcription factor 1
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA]
|
CTD |
PMID:25164625 |
|
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:50,674,678...50,677,653
|
|
G
|
Tyr
|
tyrosinase
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of TYR gene
|
CTD |
PMID:17174358 |
|
NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:141,115,036...141,210,207
|
|
G
|
Tyrp1
|
tyrosinase-related protein 1
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of TYRP1 gene
|
CTD |
PMID:17174358 |
|
NCBI chr 5:100,327,111...100,345,657
Ensembl chr 5:95,280,982...95,299,516
|
|
G
|
Ubac2
|
UBA domain containing 2
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of UBAC2 gene
|
CTD |
PMID:16868089 |
|
NCBI chr15:105,366,776...105,514,435
Ensembl chr15:98,960,139...99,107,787
|
|
G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of UBE2C mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:153,506,636...153,513,339
|
|
G
|
Ube2j1
|
ubiquitin-conjugating enzyme E2, J1
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of UBE2J1 mRNA
|
CTD |
PMID:17412507 |
|
NCBI chr 5:52,218,807...52,237,805
Ensembl chr 5:47,422,587...47,441,461
|
|
G
|
Upp1
|
uridine phosphorylase 1
|
increases expression decreases expression
|
EXP ISO
|
Methylnitrosourea results in increased expression of UPP1 mRNA Methylnitrosourea results in decreased expression of UPP1 mRNA
|
CTD |
PMID:17412507 PMID:25270620 |
|
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions increases expression
|
ISO EXP
|
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] [Methylnitrosourea co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of VEGFA mRNA
|
CTD |
PMID:16822543 PMID:20732338 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G
|
Vim
|
vimentin
|
multiple interactions
|
EXP
|
[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein]
|
CTD |
PMID:25164625 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|
G
|
Vrk1
|
VRK serine/threonine kinase 1
|
decreases expression multiple interactions
|
ISO
|
Methylnitrosourea results in decreased expression of VRK1 protein TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein]
|
CTD |
PMID:27233451 |
|
NCBI chr 6:124,914,770...124,981,508
Ensembl chr 6:124,914,855...124,981,436
|
|
G
|
Wdr35
|
WD repeat domain 35
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of WDR35 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
|
|
G
|
Wnt5a
|
Wnt family member 5A
|
increases expression increases expression
|
EXP
|
Methylnitrosourea results in increased expression of WNT5A mRNA N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon
|
CTD RGD |
PMID:17341692 PMID:28032729 |
RGD:150530464 |
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
|
|
G
|
Xiap
|
X-linked inhibitor of apoptosis
|
decreases response to substance
|
ISO
|
XIAP protein results in decreased susceptibility to Methylnitrosourea
|
CTD |
PMID:12766084 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
|
|
G
|
Xrcc5
|
X-ray repair cross complementing 5
|
increases mutagenesis
|
ISO
|
Methylnitrosourea results in increased mutagenesis of XRCC5 gene
|
CTD |
PMID:16868089 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of ZEB1 mRNA
|
CTD |
PMID:27221058 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:51,948,948...52,115,214
|
|
G
|
Zfp365
|
zinc finger protein 365
|
increases expression
|
ISO
|
Methylnitrosourea results in increased expression of ZFP365 mRNA
|
CTD |
PMID:25270620 |
|
NCBI chr20:20,665,122...20,688,607
Ensembl chr20:20,666,240...20,691,238
|
|
G
|
Znf8
|
zinc finger protein 8
|
increases expression
|
EXP
|
Methylnitrosourea results in increased expression of ZFP128 mRNA
|
CTD |
PMID:16525678 |
|
NCBI chr 1:73,498,526...73,511,929
Ensembl chr 1:73,498,491...73,511,119
|
|